Home › Cervical Cancer › NCT00005095
Specimen and Data Study for Ovarian Cancer Early Detection and Prevention
RecruitingObservational studyHealthy volunteers welcome
Northwestern Ovarian Cancer Early Detection & Prevention Program: A Specimen and Data Study
Who can join
Ages 18 to 80 · Women · Healthy volunteers welcome
Full eligibility criteria
DISEASE CHARACTERISTICS:
* Meets one of the following criteria:
* Considered to be at increased risk for developing ovarian cancer, as defined by one of the following:
* Has at least one first-degree relative (mother, sister, or daughter) with ovarian, primary peritoneal, or fallopian tube cancer
* Has at least two first or second degree relatives diagnosed before age 50 with either ovarian, primary peritoneal, fallopian tube, and/or pancreatic cancer who have tested positive for hereditary cancer syndrome that includes an increased risk of gynecologic cancer (e.g., BRCA1/2 or Lynch Syndrome)or have increased risk as deemed by a certified genetic counselor
* A personal or family history of a hereditary cancer syndrome that includes an increased risk of gynecologic cancer
* Increased risk as deemed by a certified genetic counselor
* Undergoing surgery for a gynecologic condition, including any of the following:
* Diagnosis of a reproductive cancer
* Benign gynecological condition (e.g., uterine leiomyomata, endometriosis, pelvic inflammatory disease, or follicular or corpus luteum ovarian cysts)
* Highly suspicious adnexal mass
* Risk-reducing prophylactic oophorectomy
PATIENT CHARACTERISTICS:
Age
* Between the ages of 18 and 80About the study
RATIONALE: To improve strategies for detection and prevention of early-stage disease.
PURPOSE: This research study is collecting specimens and data to develop better methods for early detection and prevention of ovarian cancer among the high risk population and those who have the disease.
What is being tested
- Ca-125 (other)
- screening questionnaire administration (other)
- Surgery (procedure)
Sponsor: Northwestern University · Participants: 6,000 · Started: 2000-03
Contact the study team
- Takelia Walker · Phone: 3125034802
- Anne Grace · Phone: 312-503-4165
Official record on ClinicalTrials.gov — NCT00005095
Locations in the U.S.
| Illinois | Robert H. Lurie Comprehensive Cancer Center at Northwestern University, Chicago |
Conditions
- Cervical Cancer
- Endometrial Cancer
- Ovarian Cancer
- Breast Cancer
- Soft Tissue Sarcoma
- Vaginal Cancer
- Vulvar Cancer
- Ovarian Epithelial Carcinoma
From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.